Recent developments in immunotherapy of cancers caused by human papillomaviruses.

Immunology
Elham FakhrAngel Cid-Arregui

Abstract

A subset of oncogenic human papillomaviruses (HPVs) is the main cause of genital cancers, most importantly cervical cancer and an increasing number of head and neck cancers. Despite the availability of prophylactic vaccines against the most prevalent oncogenic HPV types, HPV-induced malignancies are still a major health and economic burden. Besides conventional treatment with surgery, chemotherapy and radiation, immunotherapy is emerging as an efficient adjuvant option. Here, we review relevant studies and ongoing clinical trials using immune checkpoint inhibitors, therapeutic vaccines, gene editing approaches and adoptive T cell therapies, with special focus on engineered TCR T cells, which are showing encouraging results and could lead to significant improvement in the treatment of HPV+-infected cancer patients.

References

Sep 19, 2000·American Journal of Obstetrics and Gynecology·K ElfgrenJ Dillner
Jun 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·K C GarciaE S Ward
Feb 7, 2003·The New England Journal of Medicine·Nubia MuñozUNKNOWN International Agency for Research on Cancer Multicenter Cervical Cancer Study Group
Jun 9, 2004·Virology·Ethel-Michele de VilliersHarald zur Hausen
Sep 6, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yangbing ZhaoRichard A Morgan
Nov 15, 2005·International Journal of Cancer. Journal International Du Cancer·Thomas K HoffmannTheresa L Whiteside
Jul 25, 2006·Blood·Moniek A de WitteTon N M Schumacher
Jan 2, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cornelia L TrimbleT C Wu
May 12, 2009·Immunological Reviews·Gregory DriessensThomas F Gajewski
Feb 4, 2010·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Ken LinT C Wu
Mar 5, 2010·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Jun-Han SuT-C Wu
Jul 2, 2010·Nature Reviews. Cancer·Cary A Moody, Laimonis A Laimins
Jan 1, 2009·Methods in Enzymology·Kurt H PiepenbrinkBrian M Baker
May 1, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Astar Haga-FriedmanCyrille J Cohen
Jan 31, 2014·Science Translational Medicine·Leonel MaldonadoCornelia L Trimble
Oct 23, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wencheng DingHui Wang
Dec 17, 2014·The Journal of Clinical Investigation·Zheng HuHui Wang
Dec 30, 2014·Expert Opinion on Biological Therapy·Vítor GasparFani Sousa
Apr 1, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sanja StevanovićChristian S Hinrichs
May 20, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S Pils, E A Joura
Jun 3, 2015·Disease Models & Mechanisms·Michaela Sharpe, Natalie Mount
Oct 3, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lindsey M DraperChristian S Hinrichs
Aug 27, 2016·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Magdalena NauerthDirk H Busch
Oct 13, 2016·Journal of Translational Medicine·José Eduardo VargasMartin H Bonamino
Nov 5, 2016·Journal of Biomedical Science·Andrew YangChien-Fu Hung
Apr 4, 2017·International Journal of Cancer. Journal International Du Cancer·Catherine de MartelSilvia Franceschi
May 26, 2017·Cancer·Erez Nissim BaruchGal Markel
Jul 12, 2017·BMC Biotechnology·Elisa RosatiAndre Franke
Dec 27, 2017·Papillomavirus Research·Aleyo ChabedaInga I Hitzeroth

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

PepCan
LigandTracer

Related Concepts

Related Feeds

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Molecular Carcinogenesis
H zur Hausen
Anales de la Real Academia Nacional de Medicina
M C Maroto Vela
Cancers
Maria Lina Tornesello, Franco M Buonaguro
© 2021 Meta ULC. All rights reserved